Literature DB >> 22865474

Anterior cingulate integrity: executive and neuropsychiatric features in Parkinson's disease.

Simon J G Lewis1, James M Shine, Shantel Duffy, Glenda Halliday, Sharon L Naismith.   

Abstract

Patients with advanced Parkinson's disease (PD) commonly suffer with significant executive dysfunction and concomitant visual hallucinations. Although the underlying pathophysiology remains poorly understood, numerous studies have highlighted the strong association between these neuropsychiatric features, suggesting common neural pathways. Although previous neuroimaging studies have identified widespread volume loss across a number of cortical regions, to date, no studies have utilized proton magnetic resonance spectroscopy to provide insights into how neurometabolic changes may relate to such symptoms. Twenty patients with PD and 20 healthy controls underwent spectroscopy to determine the N-acetyl aspartate/creatine (NAA/Cr) ratio, which reflects the degree of neuronal integrity in neurodegenerative diseases. Voxels were obtained from the anterior cingulate cortex (ACC), an area critical for a wide range of executive mechanisms as well as from a control volume in the posterior cingulate cortex (PCC). Compared to controls, patients with PD had lower NAA/Cr ratios in the ACC. In turn, lower NAA/Cr ratios significantly correlated with poorer executive function on tasks of attentional set-shifting and response inhibition, as well as more-severe psychotic symptoms and poorer performance on the Bistable Percept Paradigm, a neuropsychological probe of visual hallucinations. NAA/Cr ratios were significantly lower in hallucinators, compared to nonhallucinators, within the ACC, but did not differ in the PCC. These results suggest that loss of neuronal integrity within the ACC plays an important role in the pathophysiology underlying executive functioning and visual hallucinations in PD. © 2012 Movement Disorder Society.
Copyright © 2012 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22865474     DOI: 10.1002/mds.25104

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  14 in total

1.  The role of dysfunctional attentional control networks in visual misperceptions in Parkinson's disease.

Authors:  James M Shine; Glenda M Halliday; Moran Gilat; Elie Matar; Samuel J Bolitho; Maria Carlos; Sharon L Naismith; Simon J G Lewis
Journal:  Hum Brain Mapp       Date:  2013-06-13       Impact factor: 5.038

2.  Proton Magnetic Resonance Spectroscopy for the Early Diagnosis of Parkinson Disease in the Substantia Nigra and Globus Pallidus: A Meta-Analysis With Trial Sequential Analysis.

Authors:  Wenbin Gu; Chen He; Juping Chen; Junchen Li
Journal:  Front Neurol       Date:  2022-06-16       Impact factor: 4.086

Review 3.  The utility of neuroimaging in the differential diagnosis of parkinsonian syndromes.

Authors:  Florian Holtbernd; David Eidelberg
Journal:  Semin Neurol       Date:  2014-06-25       Impact factor: 3.420

4.  Validation of the Psychosis and Hallucinations Questionnaire in Non-demented Patients with Parkinson's Disease.

Authors:  James M Shine; Joanna M Z Mills; Jessica Qiu; Claire O'Callaghan; Zoe Terpening; Glenda M Halliday; Sharon L Naismith; Simon J G Lewis
Journal:  Mov Disord Clin Pract       Date:  2015-03-16

Review 5.  Magnetic Resonance Techniques Applied to the Diagnosis and Treatment of Parkinson's Disease.

Authors:  Benito de Celis Alonso; Silvia S Hidalgo-Tobón; Manuel Menéndez-González; José Salas-Pacheco; Oscar Arias-Carrión
Journal:  Front Neurol       Date:  2015-07-03       Impact factor: 4.003

6.  Longitudinal changes in task-evoked brain responses in Parkinson's disease patients with and without mild cognitive impairment.

Authors:  Urban Ekman; Johan Eriksson; Lars Forsgren; Magdalena E Domellöf; Eva Elgh; Anders Lundquist; Lars Nyberg
Journal:  Front Neurosci       Date:  2014-07-29       Impact factor: 4.677

7.  Metabolic Disturbances in the Striatum and Substantia Nigra in the Onset and Progression of MPTP-Induced Parkinsonism Model.

Authors:  Yi Lu; Xiaoxia Zhang; Liangcai Zhao; Changwei Yang; Linlin Pan; Chen Li; Kun Liu; Guanghui Bai; Hongchang Gao; Zhihan Yan
Journal:  Front Neurosci       Date:  2018-02-20       Impact factor: 4.677

8.  High-Order Visual Processing, Visual Symptoms, and Visual Hallucinations: A Possible Symptomatic Progression of Parkinson's Disease.

Authors:  Kelsey Barrell; Britta Bureau; Pierpaolo Turcano; Gregory D Phillips; Jeffrey S Anderson; Atul Malik; David Shprecher; Meghan Zorn; Edward Zamrini; Rodolfo Savica
Journal:  Front Neurol       Date:  2018-11-27       Impact factor: 4.003

9.  Mild cognitive impairment in Parkinson's disease: a review of current concepts.

Authors:  Natalie C Palavra; Sharon L Naismith; Simon J G Lewis
Journal:  Neurol Res Int       Date:  2013-07-01

Review 10.  Magnetic resonance spectroscopy: an in vivo molecular imaging biomarker for Parkinson's disease?

Authors:  Rosella Ciurleo; Giuseppe Di Lorenzo; Placido Bramanti; Silvia Marino
Journal:  Biomed Res Int       Date:  2014-09-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.